期刊文献+

聚乙二醇修饰超氧化物歧化酶衍生物的制备及其放射性碘标记 被引量:3

Preparation of Superoxide Dismutase Derivative with Polyethylene Glycol Mono Methyl Ether and Its Labeling with Radioactive I^(125)
下载PDF
导出
摘要 目的制备聚乙二醇(PEG)修饰超氧化物歧化酶(SOD)衍生物并对其进行放射性碘标记。方法将PEG中加入干苯、PEG单甲醚、氰尿酰氯及无水碳酸钾进行活化,并将活化产物逐渐加入到溶解有SOD的pH9.2四硼酸钠溶液中,制备得PEG-SOD衍生物,经葡聚糖凝胶G75纯化后,以氯胺T与碘125化钠进行放射性标记,并计算标记物的比放射性。结果经葡聚糖凝胶G75纯化后PEG-SOD衍生物的蛋白回收率达到74.1%,碘标记的PEG-SOD比放射性平均值为1.47mCi/mg。结论本文建立的PEG-SOD衍生物制备工艺可行,标记的PEG-SOD符合药理学实验要求,可用于药理学的实验研究。 OBJECTIVE: To prepare the SOD derivative with PEG and its labeling with I^125. METHODS: PEG was activated by cyanuric chloride, polyethylene mono methyl ether and anhydr- carbonicum kalium in absolute benzene. The activated PEG was added to sodium tetraborate solution with pH9.2 with SOD, thus to get derivative of PEG- SOD, which, being purified by dextran gel G75, was labeled with I^125 and chloramines- T oxidation, and the specific radioactivity of the marker was counted. RESULTS: After purified by dextran gel G75, the protein recovery of derivative of PEG - SOD was as high as 74.1%, and the purified PEG-SOD labeled with I^125 had a average radioactivity of 1.47mCi/mg. CONCLUSION: The technology put forward in this paper is practical for preparing PEG - SOD derivative. And the labeled PEG - SOD can meet the requirement of pharmacological experiment, and can be adopted into relevant researches.
出处 《中国药房》 CAS CSCD 北大核心 2006年第12期911-912,共2页 China Pharmacy
基金 国家自然科学基金资助项目(B5128197)
关键词 聚乙二醇 超氧化物歧化酶 衍生物 制备 放射性碘标记 Polyethylene Superoxide dismutase Derivate Preparation Label of I^125
  • 相关文献

参考文献3

二级参考文献8

  • 1阎家麒,中国医药工业杂志,1992年,23卷,481页
  • 2区耀华,生物化学与生物物理进展,1989年,16卷,203页
  • 3袁勤生,中国医药工业杂志,1989年,20卷,351页
  • 4张元亮,生化药物杂志,1987年,1期,17页
  • 5吴云,生物化学与生物物理进展,1986年,18卷,308页
  • 6张龙翔,生化实验方法和技术,1981年
  • 7龚雄麒,国外医学药学分册,1988年,2期,65页
  • 8袁勤生,医药工业,1986年,17卷,4期,201页

共引文献22

同被引文献61

  • 1孔庆胜,迮玉官.聚乙二醇修饰超氧化物歧化酶的基础研究[J].济宁医学院学报,2006,29(1):16-17. 被引量:8
  • 2Huang JZ,Lemire BD.Mutations in the C.elegans succinate dehydrogenase iron-sulfur subunit promote superoxide generation and premature aging[J].J Mol Biol,2009;387:559-69.
  • 3Monari M,Trinchero A,Calabrese C.Superoxide dismutase in gastric adenocarcinoma:is it a clinical biomarker in the development of cancer[J]? Biomarkers,2006;11(6):574-84.
  • 4Weydert CJ,Waugh TA,Ritchie JM.Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth[J].Free Radic Biol Med,2006;41(2):226-37.
  • 5Noda J,Otagifi M,Akaike T,et al.Pharmacological advantages of conjugation of Cu,Zn-superoxide dismutase with succinylated keratin fragment:improvement of biological properties and resistance to oxidative damage[J].J Pharmacol Exp Ther,1996;279(1):162-71.
  • 6Tasaki H,Yamashita K.Heparin-released extracellular superoxide dismutase is reduced in patients with coronary artery atherosclerosis[J].Atherosclerosis (Amsterdam,Netherlands),2006;187(1):131-8.
  • 7Valdivia A,Perez Y,Ramirez H,et al.Improved pharmacological properties for superoxide dismutase modified with β-cyclodextrin-carboxymethylcellulose polymer[J].Biotechnology Letters,2006;28(18):1465-70.
  • 8Maksimenko AV.Experimental antioxidant biotherapy for protection of the vascular wall by modified forms of super oxide dismutase and catalase[J].Current Pharmaceutical Design,2005;11(16):2007-16.
  • 9Pong K.Oxidative stress in neurodegenerative diseases:therapeutic implications for superoxide dismutase mimetics[J].Expert Opin Biol Ther,2003;3(1):127-39.
  • 10Peng J,Stevenson FF,Doctrow SR,et al.Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra:implications for Parkinson disease[J].J Biol Chem,2005;280(32):29194-8.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部